MET and cancer: Different important target genes have been validated in different cancers, such as the transcriptional regulator PHF10 [22], the pro-metastatic gene radixin [23], the pro-angiogenic gene angiogenin (ANG) [24], the oncoprotein GAB1 [27] and the pro-metastatic gene c-Met [25].